Skip to Content

During the funding lapse, is not being supported. If data feeds are not available from GPO, will not be updated, so please use the official edition of the Federal Register on Govinfo ( If there is a technical issue with the Public Inspection List, you can view the documents on public inspection at our office in Washington, DC or on


National Center for Complementary & Alternative Medicine; Notice of Closed Meeting

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Cancer Advisory Panel for Complementary and Alternative Medicine.

The meeting will be closed to the public in accordance with the provisions set forth in section 552b(c)(9)(B), Title 5 U.S.C., as amended because the premature disclosure of program documents—PAC and the discussions would likely to significantly frustrate implementation of recommendations.

Name of Committee: Cancer Advisory Panel for Complementary and Alternative Medicine.

Date: April 19, 2000.

Time: 2:30 PM to 5:00 PM.

Agenda: To review and evaluate the Gonzalez Regiment.

Place: National Institutes of Health, 9000 Rockville Pike, Bldg. 31, Room 5B5B, Bethesda, MD 20892, (Telephone Conference Call).

Contact Person: Richard Nahin, PhD, Executive Secretary, Cancer Advisory Panel for Complementary, and Alternative Medicine, NCCAM, NIH, 9000 Rockville Pike, Building 31, Room 5B37, Bethesda, MD 20892, 301-594-2013.

This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

Start Signature

Dated: April 6, 2000.

Anna Snouffer,

Acting Director, Office of Federal Advisory Committee Policy.

End Signature End Preamble

[FR Doc. 00-9436 Filed 4-14-00; 8:45 am]